References to Primary Literature
- CHEE MS, BANKIER AT, BECK S, BOHNI R, BROWN CM, CERNY R, HORSNELL T, HUTCHINSON CA 3rd, KOUZARIDES T, MARTIGNETTI JA, PREDDIE E, SATCH-WELL SC, TOMLINSON P. WESTON KM, BARBELL BG: Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr, Top. Microb. Immunol. (1990) 154:125–169.
- NEYTS J, DECLERCQ E: Strategies for the treatment and prevention of cytomegalovirus infections. Intl. Antimi-crob. Agents (1993) 3:187–204.
- AZAD RE etal.: Antiviral activity of a phosphorothioate oligonucleotide complementary to RNA of the human cytomegalovirus major immediate-early region. Antimi-crab. Agents Chemother. (1993) 37:1945–1954.
- AZAD RF etal.: Antiviral activity of a phosphorothioate oligonudeotide complementary to human cytomega-lovirus RNA when used in combination with antiviral nucleoside analogs. Antiviral Research (1995) 28:101–111.
References to Patent Literature
- US9105815 (1991)